Thrombin generation in acute cardioembolic and non-cardioembolic ischemic stroke

References

• Connolly SJ, Ezekowitz MD, Yusuf S, Eikelboom J, Oldgren J, Parekh A, Pogue J, Reilly PA, Themeles E, Varrone J, Wang S, Alings M, Xavier D, Zhu J, Diaz R, Lewis BS, Darius H, Diener HC, Joyner CD, Wallentin L. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med 2009;361:1139–51.
   PubMed Web of Science ®Google Scholar
• Carcaillon L, Alhenc-Gelas M, Bejot Y, Spaft C, Ducimetiere P, Ritchie K, Dartigues JF, Scarabin PY. Increased thrombin generation is associated with acute ischemic stroke but not with coronary heart disease in the elderly: the Three-City cohort study. Arterioscler Thromb Vasc Biol 2011;31:1445–51.
   PubMed Web of Science ®Google Scholar
• Castoldi E, Rosing J. Thrombin generation tests. Thromb Res 2011;127(Suppl. 3):S21–25.
   PubMed Web of Science ®Google Scholar
• Doliwa PS, Frykman V, Rosenqvist M. Short-term ECG for out of hospital detection of silent atrial fibrillation episodes. Scand Cardiovasc J 2009;43:163–8.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Cerebrovascular disorders: a clinical and research classification. Geneva: WHO, 1978.
   Google Scholar
• Sorensen AG, Ay H. Transient ischemic attack: definition, diagnosis, and risk stratification. Neuroimaging Clin N Am 2011;21:303–13.
   Google Scholar
• Doliwa Sobocinski P, Änggårdh Rooth E, Frykman Kull V, von Arbin M, Wallén H, Rosenqvist M. Improved screening for silent atrial fibrillation after ischemic stroke. Europace 2012;14:1112–6.
   PubMed Web of Science ®Google Scholar
• Hemker H, Giesen P, Al Dieri R. The calibrated automated thrombogram (CAT): a universal routine test for hyper- and hypocoagulability. Pathophysiol Haemost Thromb 2002;32: 249–53.
   PubMed Web of Science ®Google Scholar
• Hemker HC, Béguin S. Thrombin generation in plasma: its assessment via the endogenous thrombin potential. Thromb Haemost 1995;74:134–8.
   PubMed Web of Science ®Google Scholar
• Brott T, Adams H Jr, Olinger C, Marler J, Barsan W, Biller J, Spilker J, Hollercan R, Eberle R, Hertzberg V, et al. Measurements of acute cerebral infarction: a clinical examination scale. Stroke 1989;20:864–70.
   PubMed Web of Science ®Google Scholar
• Adams H Jr, Bendixen B, Kapelle L, Biller J, Love B, Gordon D, Marsh E III. Classification of subtype of acute ischemic stroke-definitions for use in a multicenter clinical trial. TOAST. Trial of Org10172 in Acute Stroke Treatment. Stroke 1993;24:35–41.
   PubMed Web of Science ®Google Scholar
• Chronic Kidney Disease Prognosis Consortium. Comparison of prediction using the CKD-EPI equation and the MDRD-study equation for estimated glomerular filtration rate. JAMA 2012;307:1974–51. http://www.kidney.org/professionals/kdoqi/gfr_calculator.cfm>
   Google Scholar
• Gissel M, Undas A, Slowik A, Mann KG, Brummel- Ziedins KE. Plasma factor and inhibitor composition contributes to thrombin generation dynamics in patients with acute or previous cerebrovascular events. Thromb Res 2010;126:262–9.
   PubMed Web of Science ®Google Scholar
• Smid M, Dielis AW, Winkens M, Spronk HM, van Oerle R, Hamulyak K, Prins MH, Rosing J, Waltenberger JL, ten Cate H. Thrombin generation in patients with a first acute myocardial infarction. J Thromb Haemost 2011;9:450–6.
   PubMed Web of Science ®Google Scholar
• Lip GY. Does atrial fibrillation confer a hypercoagulable state? Lancet 1995;346:1313–4.
   PubMed Web of Science ®Google Scholar
• Turgut N, Akdemir O, Turgut B, Demir M, Ekuklu G, Vural O, Ozbay G, Utku U. Hypercoagulopathy in stroke patients with nonvalvular atrial fibrillation: hematologic and cardiologic investigations. Clin Appl Thromb Hemost 2006;12:15–20.
   PubMed Web of Science ®Google Scholar
• Yamazaki M, Uchiyama S, Maruyama S. Alterations of haemostatic markers in various subtypes and phases of stroke. Blood Coagul Fibrinolysis 1993;4:707–12.
   PubMed Web of Science ®Google Scholar
• Glotzer TV, Daoud EG, Wyse DG, Singer DE, Ezekowitz MD, Hilker C, Miller C, Qi D, Ziegler PD. The relationship between daily atrial tachyarrhythmia burden from implantable device diagnostics and stroke risk: the TRENDS study. Circ Arrhythm Electrophysiol 2009; 2:474–80.
   PubMed Web of Science ®Google Scholar
• Binici Z, Intzilakis T, Nielsen OW, Kober L, Sajadieh A. Excessive supraventricular ectopic activity and increased risk of atrial fibrillation and stroke. Circulation 2010; 121:1904–11.
   PubMed Web of Science ®Google Scholar
• Raed Al Dieri, Bas de Laat, Hemker HC. Thrombin generation; what have we learned? Blood Rev 2012;26:197–203.
   Google Scholar
• Duchemin J, Pan-Petesch B, Arnaud B, Blouch MT, Abgrall JF. Influence of coagulation factors and tissue factor concentration on the thrombin generation test in plasma. Thromb Haemost 2008;99:767–73.
   PubMed Web of Science ®Google Scholar
• Furie KL, Rosenberg R, Thompson JL, Bauer K, Mohr JP, Rosner B, Sciacca R, Barzegar B, Thornell B, Costigan T, Kistler JP. Thrombin generation in noncardioembolic stroke subtypes: the Hemostatic System Activation Study. Neurology 2004;63:777–84.
   Google Scholar
• Faber C, Lodder J, Kessels F, Troost J. Thrombin generation in platelet rich plasma as a tool for the detection of hypercoagulability in young stroke patients. Pathophysiol Haemost Thromb 2003;33:52–8.
   Google Scholar
• Tehrani S, Mobarrez F, Antovic A, Santesson P, Lins PE, Adamson U, Henriksson P, Wallen NH, Jorneskog G. Atorvastatin has antithrombotic effects in patients with type 1 diabetes and dyslipidemia. Thromb Res 2010;126:225–31.
   PubMed Web of Science ®Google Scholar
• Undas A, Celinska-Lowenhoff M, Brummel-Ziedins KE, Brozek J, Szczeklik A, Mann KG. Simvastatin given for 3 days can inhibit thrombin generation and activation of factor V and enhance factor Va inactivation in hypercholesterolemic patients. Arterioscler Thromb Vasc Biol 2005;25:1524–25.
   PubMed Web of Science ®Google Scholar
• Mobarrez F, He S, Broijersen A, Wiklund B, Antovic A, Antovic J, Egberg N, Jorneskog G, Wallen H. Atorvastatin reduces thrombin generation and expression of tissue factor, P-selectin and GPIIIa on platelet-derived microparticles in patients with peripheral arterial occlusive disease. Thromb Haemost 2011;106:344–52.
   PubMed Web of Science ®Google Scholar
• Ekholm M, Wallen NH, Johnsson H, Eliasson K, Kahan T. Long-term angiotensinconverting enzyme inhibition with ramipril reduces thrombin generation in human hypertension. Clin Sci (Lond) 2002;103:151–5.
   Google Scholar
• Bratseth V, Pettersen A-Å, Opstad TB, Arnesen H, Seljeflot I. Markers of hypercoagulability in CAD patients. Effects of single aspirin and clopidogrel treatment. Thromb J 2012;10.
   Google Scholar
• Rooth E, Wallen NH, Blomback M, He S. Decreased fibrin network permeability and impaired fibrinolysis in the acute and convalescent phase of ischemic stroke. Thromb Res 2011;127:51–6.
   Google Scholar